Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

Tea, hormone-related cancers and endogenous hormone levels.

Wu AH, Yu MC.

Mol Nutr Food Res. 2006 Feb;50(2):160-9. Review.

PMID:
16470648
2.

Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.

Stuart EC, Scandlyn MJ, Rosengren RJ.

Life Sci. 2006 Nov 17;79(25):2329-36. Epub 2006 Aug 5. Review.

PMID:
16945390
3.

Endogenous hormones as a major factor in human cancer.

Henderson BE, Ross RK, Pike MC, Casagrande JT.

Cancer Res. 1982 Aug;42(8):3232-9. Review.

4.

Prostate cancer chemoprevention by green tea.

Gupta S, Ahmad N, Mukhtar H.

Semin Urol Oncol. 1999 May;17(2):70-6. Review.

PMID:
10332919
5.

Tea and cancer: a review of the epidemiological evidence.

Blot WJ, Chow WH, McLaughlin JK.

Eur J Cancer Prev. 1996 Dec;5(6):425-38. Review.

PMID:
9061273
6.

Tea and cancer prevention: studies in animals and humans.

Chung FL, Schwartz J, Herzog CR, Yang YM.

J Nutr. 2003 Oct;133(10):3268S-3274S. Review.

7.

An overview of hormone-associated cancers.

Miller AB.

Cancer Res. 1978 Nov;38(11 Pt 2):3985-90. Review.

8.

Tea, coffee and prostate cancer.

Lee AH, Fraser ML, Binns CW.

Mol Nutr Food Res. 2009 Feb;53(2):256-65. doi: 10.1002/mnfr.200800218. Review.

PMID:
18985656
9.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
11.

Endocrine factors in human carcinogenesis.

Armstrong B.

IARC Sci Publ. 1982;(39):193-221. Review.

PMID:
6759385
12.

Protective effects of green tea against prostate cancer.

Lee AH, Fraser ML, Meng X, Binns CW.

Expert Rev Anticancer Ther. 2006 Apr;6(4):507-13. Review.

PMID:
16613539
13.
14.

Physical activity and cancer prevention: etiologic evidence and biological mechanisms.

Friedenreich CM, Orenstein MR.

J Nutr. 2002 Nov;132(11 Suppl):3456S-3464S. Review.

15.

Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1.

Kim J, Zhang X, Rieger-Christ KM, Summerhayes IC, Wazer DE, Paulson KE, Yee AS.

J Biol Chem. 2006 Apr 21;281(16):10865-75. Epub 2006 Feb 22.

16.

Tea beverage in chemoprevention and chemotherapy of prostate cancer.

Siddiqui IA, Saleem M, Adhami VM, Asim M, Mukhtar H.

Acta Pharmacol Sin. 2007 Sep;28(9):1392-408. Review.

17.

Systematic review: green tea and gastrointestinal cancer risk.

Borrelli F, Capasso R, Russo A, Ernst E.

Aliment Pharmacol Ther. 2004 Mar 1;19(5):497-510. Review.

PMID:
14987318
18.

Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancers.

Ness RB, Modugno F.

Eur J Cancer. 2006 Apr;42(6):691-703. Epub 2006 Mar 13. Review.

PMID:
16531042
19.

Tea consumption and epithelial ovarian cancer risk: a systematic review of observational studies.

Oppeneer SJ, Robien K.

Nutr Cancer. 2011;63(6):817-26. doi: 10.1080/01635581.2011.594210. Epub 2011 Jul 29. Review.

PMID:
21800977

Supplemental Content

Support Center